Filtra per Last updated date SelectDopoPrimaFrom - To Date Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Esito (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank COVID-19: EMA recommends authorisation of antibody medicine Xevudy 16 Dicembre 2021NewsHumanCOVID-19Medicines EMA recommends approval for use of Kineret in adults with COVID-19 16 Dicembre 2021NewsHumanCOVID-19 EMA launches the Regulatory Science Research Needs initiative 15 Dicembre 2021NewsHumanResearch and development COVID-19 Vaccine Janssen: EMA recommendation on booster dose 15 Dicembre 2021NewsHumanCOVID-19Vaccines EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19 14 Dicembre 2021NewsHumanCOVID-19Medicines International regulators’ reflections on remote approaches to GCP and GMP regulatory oversight during COVID-19 pandemic 13 Dicembre 2021NewsHumanCOVID-19 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 December 2021 10 Dicembre 2021NewsVeterinaryMaximum residue limitMedicines International regulators stress continued need for COVID-19 therapeutics 10 Dicembre 2021NewsHumanCOVID-19Medicines EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: ‘mix-and-match’ approach can be used for both initial courses and boosters 7 Dicembre 2021NewsHumanCOVID-19Vaccines ICMRA high-level meeting on global health emergencies and regulatory approaches 6 Dicembre 2021NewsHumanCOVID-19MedicinesVaccines 1 … 52 53 54 55 56 Page 56 of 383 57 58 59 60 … 383
COVID-19: EMA recommends authorisation of antibody medicine Xevudy 16 Dicembre 2021NewsHumanCOVID-19Medicines
EMA launches the Regulatory Science Research Needs initiative 15 Dicembre 2021NewsHumanResearch and development
COVID-19 Vaccine Janssen: EMA recommendation on booster dose 15 Dicembre 2021NewsHumanCOVID-19Vaccines
EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19 14 Dicembre 2021NewsHumanCOVID-19Medicines
International regulators’ reflections on remote approaches to GCP and GMP regulatory oversight during COVID-19 pandemic 13 Dicembre 2021NewsHumanCOVID-19
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 December 2021 10 Dicembre 2021NewsVeterinaryMaximum residue limitMedicines
International regulators stress continued need for COVID-19 therapeutics 10 Dicembre 2021NewsHumanCOVID-19Medicines
EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: ‘mix-and-match’ approach can be used for both initial courses and boosters 7 Dicembre 2021NewsHumanCOVID-19Vaccines
ICMRA high-level meeting on global health emergencies and regulatory approaches 6 Dicembre 2021NewsHumanCOVID-19MedicinesVaccines